- Home
- UNCY vs DIBS Comparison
UNCY vs DIBS Comparison
Compare UNCY & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNCY | DIBS |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | United States |
| Employees | N/A | 266 |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.3M | 162.5M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | UNCY | DIBS |
|---|---|---|
| Price | $8.12 | $4.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $25.67 | $7.00 |
| AVG Volume (30 Days) | ★ 523.7K | 226.2K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.45 |
| EPS | N/A | ★ N/A |
| Revenue | $675,000.00 | ★ $89,620,000.00 |
| Revenue This Year | N/A | $3.12 |
| Revenue Next Year | $582.86 | $1.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.54 |
| 52 Week Low | $0.47 | $2.37 |
| 52 Week High | $8.74 | $6.62 |
Technical Indicators
Market Signals| Indicator | UNCY | DIBS |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 43.45 |
| Support Level | $5.95 | $4.38 |
| Resistance Level | $8.54 | $4.87 |
| Average True Range (ATR) | 0.44 | 0.31 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 55.04 | 77.24 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company has a single reportable and operating segment that contains one reporting unit, which consists of the company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.